The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells

Motoaki Sano, Keiichi Fukuda

Research output: Contribution to journal › Article

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1249-1251
Number of pages3
JournalCancer Biology and Therapy
Volume8
Issue number13
Publication statusPublished - 2009 Jul 1

Fingerprint

Drug Dose Response Relationship
Phthalazines
Pyridines
Vascular Endothelial Growth Factor Receptor-1
Biological Models
Gene Expression Profiling
Protein Kinase Inhibitors
Reverse Transcriptase Polymerase Chain Reaction
Mesenchymal Stromal Cells
Bone Marrow Cells
Protein-Tyrosine Kinases
Vascular Endothelial Growth Factor A
Cell Movement
Cell Differentiation
Cultured Cells
Bone Marrow
Western Blotting
Cell Proliferation
Apoptosis
vatalanib

Keywords

  • Anti-tumor therapy
  • Mesenchymal stem cells
  • PDGF
  • PZK/ZK (Vatalanib)
  • VEGF
  • VEGFR inhibitor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells. / Sano, Motoaki; Fukuda, Keiichi.

In: Cancer Biology and Therapy, Vol. 8, No. 13, 01.07.2009, p. 1249-1251.

Research output: Contribution to journal › Article

Sano, M & Fukuda, K 2009, 'The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells', Cancer Biology and Therapy, vol. 8, no. 13, pp. 1249-1251.
Sano M, Fukuda K. The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells. Cancer Biology and Therapy. 2009 Jul 1;8(13):1249-1251.
Sano, Motoaki ; Fukuda, Keiichi. / The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells. In: Cancer Biology and Therapy. 2009 ; Vol. 8, No. 13. pp. 1249-1251.
@article{b645f29c921946288ce6100b35cb236c,
title = "The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells",
keywords = "Anti-tumor therapy, Mesenchymal stem cells, PDGF, PZK/ZK (Vatalanib), VEGF, VEGFR inhibitor",
author = "Motoaki Sano and Keiichi Fukuda",
year = "2009",
month = "7",
day = "1",
language = "English",
volume = "8",
pages = "1249--1251",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "13",

}

TY - JOUR

T1 - The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells

AU - Sano, Motoaki

AU - Fukuda, Keiichi

PY - 2009/7/1

Y1 - 2009/7/1

KW - Anti-tumor therapy

KW - Mesenchymal stem cells

KW - PDGF

KW - PZK/ZK (Vatalanib)

KW - VEGF

KW - VEGFR inhibitor

UR - http://www.scopus.com/inward/record.url?scp=68149158206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68149158206&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 1249

EP - 1251

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 13

ER -

Access to Document